Trajectory Analysis of NLR and Its Association With Efficacy of Immunochemotherapy in ESCC.

A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients

NCT06960889 ·Status: ACTIVE_NOT_RECRUITING

Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study

NCT05028231 ·Status: UNKNOWN

Neoadjuvant Immunotherapy to ESCC

NCT04625543 ·Status: WITHDRAWN ·Phase: PHASE2

Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma

NCT06446726 ·Status: RECRUITING ·Phase: PHASE2

Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC

NCT06603402 ·Status: RECRUITING ·Phase: PHASE2

Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC

NCT05807542 ·Status: COMPLETED ·Phase: PHASE2

Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study.

NCT06020885 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer

NCT06173986 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of the Tumor Microenvironment Affecting the Efficacy of Immunotherapy for Esophageal Cancer

NCT06219031 ·Status: COMPLETED

Dynamic Follow-up of Symptoms Based on Patient-reported Outcomes in Immunotherapy for Esophageal Cancer: a Prospective Multicentre Cohort Study (SPRING)

NCT06012318 ·Status: UNKNOWN

Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

NCT06888531 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer

NCT04207918 ·Status: COMPLETED ·Phase: PHASE2

Real-world Experience of ICIs Plus Chemotherapy With or Without Radiotherapy for Advanced ESCC.

NCT06190652 ·Status: COMPLETED

Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer

NCT03120572 ·Status: COMPLETED

Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

NCT05894369 ·Status: RECRUITING

Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer

NCT02644863 ·Status: UNKNOWN ·Phase: PHASE2

Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer

NCT07015489 ·Status: COMPLETED ·Phase: PHASE2

Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma

NCT05984342 ·Status: RECRUITING ·Phase: PHASE1

A Real-World Study of Immune Checkpoint Inhibitors and Chemotherapy for Advanced Esophageal Cancer

NCT04822103 ·Status: COMPLETED

NeoAdjuvant Therapy With Immunoreagent (SHR-1316) for Resectable Oesophageal Squamous Cell carciNoma

NCT04215471 ·Status: UNKNOWN ·Phase: PHASE2

Tumor Regression Grade As Predictor of Adjuvant Therapy

NCT06710665 ·Status: RECRUITING

Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CRIS-2 Trial）

NCT06509568 ·Status: RECRUITING ·Phase: PHASE2

Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC

NCT07236320 ·Status: COMPLETED ·Phase: NA

Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.

NCT06452602 ·Status: RECRUITING ·Phase: PHASE2

Risk Factors of Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to Neoadjuvant Chemoradiotherapy

NCT06061263 ·Status: UNKNOWN